Effect of Intravenous Versus Intrathecal Dexamethazone on Postdural Puncture Headache
Postdural Puncture Headache
About this trial
This is an interventional prevention trial for Postdural Puncture Headache focused on measuring intravenous dexamethazone, intrathecal dexamethazzone
Eligibility Criteria
Inclusion Criteria:
- Patients ASA I or II undergoing lower limb surgeries under spinal anesthesia
- Patients ASAI or II undergoing lower abdominal surgeries under spinal anesthesia.
Exclusion Criteria:
- Emergency surgeries.
- Patients with uncompensated heart diseases.
- Patients with coagulopathy.
- Presence of infection at site of injection of spinal anesthesia.
Sites / Locations
- Ain Shams University
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
intravenous dexamethazone group
intrathecal dexamethazone group
Patients receive intrathecal 3 ml heavy bupivacaine 0. 5% +1 ml normal saline + intravenous 8 mg dexamethazone in 10 ml saline,to prevent postdural puncture headache. Spinal anesthesia will be done in a sitting position under complete aseptic techniques, 25 G Quincke needle was inserted intrathecally at L3-L4 or L4-L5 interspace through midline approach. The study drugs were given by an anesthesiologist not aware of the type of medications injected.
Patients receive intrathecal 3 ml heavy bupivacaine 0.5% + 4 mg (1 ml) dexamethazone + intravenous 10 ml normal saline to prevent postdural puncture headache. Spinal anesthesia will be done in a sitting position under complete aseptic techniques, 25 G Quincke needle was inserted intrathecally at L3-L4 or L4-L5 interspace through midline approach. The study drugs were given by an anesthesiologist not aware of the type of medications injected.